Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)

China flag China · Delayed Price · Currency is CNY
9.34
+0.12 (1.30%)
Jul 29, 2025, 2:45 PM CST
1.30%
Market Cap3.69B
Revenue (ttm)1.28B
Net Income (ttm)-277.54M
Shares Out400.11M
EPS (ttm)-0.69
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume10,057,600
Average Volume5,893,717
Open9.39
Previous Close9.22
Day's Range9.29 - 9.55
52-Week Range8.18 - 25.16
Beta0.55
RSI53.25
Earnings DateAug 30, 2025

About SHA:605199

Hainan Huluwa Pharmaceutical Group Co., Ltd. research, develops, produces, and sells drugs in the areas of Children's digestive system, respiratory system, anti-infection, anti-virus and other therapeutic in China. It offers pediatrics, gynecology, antibiotics, respiratory, digestive system, cardiovascular and cerebrovascular, nourishment, and other medicine products. The company was founded in 2005 and is based in Haikou, China. [Read more]

Sector Healthcare
Founded 2005
Employees 2,103
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 605199
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.